
Scott Gottlieb, MD 🇺🇸
@scottgottliebmd
Senior Fellow @AEI. Partner @NEA. Contributor @CNBC. 23rd Commissioner of the @US_FDA. Public Boards: @Pfizer @Illumina @TempusAI
ID: 40156330
https://www.uncontrolledspread.com/ 15-05-2009 02:39:37
22,22K Tweet
544,544K Followers
3,3K Following


The FDA approved a record-breaking number of generic drugs in Trump’s first term — a major win for affordable healthcare. But now, the team behind that achievement has been disbanded, threatening that historic progress, writes Scott Gottlieb, MD 🇺🇸. statnews.com/2025/05/28/fda…


My Op Ed: President Trump often touted that his first administration approved more generic drugs than any in history. He had good reason to highlight the success. Recently, the FDA team enabling these approvals was disbanded, and it may undo that historic progress. American Enterprise Institute STAT





.Scott Gottlieb, MD 🇺🇸 discusses the impact of the Trump administration’s cuts to health research funding: cnb.cx/4l4XjKl

AEI's Scott Gottlieb, MD 🇺🇸 discusses the possibility that proposed cuts to NIH funding will have to be restored and potential next steps for the administration’s cost-cutting agenda.



